NCT00002505View on ClinicalTrials.gov

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1992

Primary Completion Date

August 31, 2002

Study Completion Date

May 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon gamma

BIOLOGICAL

tumor cell lysate vaccine therapy

Trial Locations (4)

46260

St. Vincent Hospital and Health Care Center, Indianapolis

47402

Bloomington Hospital, Bloomington

68124

Bergan Mercy Medical Center, Omaha

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00002505 - Tumor Cell Vaccine in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter